Jeremy Yethon, PhD, is Vice President, Head of Biology at Apriori Bio. He has held senior leadership roles in Discovery and Preclinical Research in both biotech and pharma. He has led teams to deliver data supporting lead nomination and mechanism of action across multiple infectious disease programs and drug modalities (vaccines, biologics, microbiome therapy).Most recently, Jeremy was VP, Head of Biology at Kaleido Biosciences. Previously, he served as Senior Director, Microbiome Sciences at Kintai Therapeutics, Senior Director, Microbiology at Seres Therapeutics, and held roles of increased responsibility at Sanofi Pasteur for 13 years.Jeremy holds a PhD from the University of Guelph, where his work on bacterial physiology was recognized by the Canadian Society of Microbiologists with its Gold Medal Award.

large_Jeremy.Yethon.jpg

Jeremy Yethon, PhD

Vice President, Head of Biology, Apriori Bio